BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36283026)

  • 1. Epidemiological and clinical characteristics of survivors of SARS-COV-2 infection: A descriptive study.
    Olavegogeascoechea PA; Gallardo Martinez A; Scapellato JL; Federico A
    Medwave; 2022 Oct; 22(9):e2581. PubMed ID: 36283026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
    Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM
    Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study.
    Feehan AK; Fort D; Velasco C; Burton JH; Garcia-Diaz J; Price-Haywood EG; Sapp E; Pevey D; Seoane L
    Clin Microbiol Infect; 2021 Apr; 27(4):633.e9-633.e16. PubMed ID: 33421576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia.
    Rocha-Filho PAS; Magalhães JE
    Cephalalgia; 2020 Nov; 40(13):1443-1451. PubMed ID: 33146035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus.
    Zurita MF; Iglesias Arreaga A; Luzuriaga Chavez AA; Zurita L
    Am J Case Rep; 2020 Sep; 21():e927304. PubMed ID: 32978364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of symptoms as a diagnostic tool for SARS-CoV 2 infection: a cross-sectional study in a cohort of 2,173 patients.
    Romero-Gameros CA; Colin-Martínez T; Waizel-Haiat S; Vargas-Ortega G; Ferat-Osorio E; Guerrero-Paz JA; Intriago-Alor M; López-Moreno MA; Cuevas-García CF; Mendoza-Zubieta V; Martínez-Ordaz JL; González-Virla B
    BMC Infect Dis; 2021 Mar; 21(1):255. PubMed ID: 33706707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Anosmia in 10.157 Pediatric COVID-19 Cases: Multicenter Study from Turkey.
    Elvan-Tuz A; Karadag-Oncel E; Kiran S; Kanik-Yuksek S; Gulhan B; Hacimustafaoglu M; Ozdem-Alatas S; Kuyucu N; Ozdemir H; Egil O; Elmas-Bozdemir S; Polat M; Bursal-Duramaz B; Cem E; Apaydin G; Teksam O;
    Pediatr Infect Dis J; 2022 Jun; 41(6):473-477. PubMed ID: 35349499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of symptoms for pediatric SARS-CoV-2 infection in a primary care setting.
    Weng CH; Butt WWW; Brooks MB; Clarke C; Jenkins HE; Holland SD; Chiang SS
    PLoS One; 2021; 16(12):e0249980. PubMed ID: 34898635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New daily persistent headache after SARS-CoV-2 infection in Latin America: a cross-sectional study.
    Carrión-Nessi FS; Ascanio LC; Pineda-Arapé AG; Omaña-Ávila ÓD; Mendoza-Millán DL; Romero SR; Almao-Rivero AB; Camejo-Ávila NA; Gebran-Chedid KJ; Rodriguez-Saavedra CM; Freitas-De Nobrega DC; Castañeda SA; Forero-Peña JL; Delgado-Noguera LA; Meneses-Ramírez LK; Cotuá JC; Rodriguez-Morales AJ; Forero-Peña DA; Paniz-Mondolfi AE
    BMC Infect Dis; 2023 Dec; 23(1):877. PubMed ID: 38097988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and natural history of the first 2073 suspected COVID-19 cases in the Corona São Caetano primary care programme: a prospective cohort study.
    Leal FE; Mendes-Correa MC; Buss LF; Costa SF; Bizario JCS; de Souza SRP; Thomaz O; Tozetto-Mendoza TR; Villas-Boas LS; de Oliveira-da Silva LC; Grespan RMZ; Capuani L; Buccheri R; Domingues H; Alexander N; Mayaud P; Sabino EC
    BMJ Open; 2021 Jan; 11(1):e042745. PubMed ID: 33436471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey on the frequency of COVID-19-like symptoms on students and staff of the University of Milan.
    Negri E; La Vecchia C
    Eur J Cancer Prev; 2021 May; 30(3):282-284. PubMed ID: 32732694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey.
    Qin S; Li Y; Wang L; Zhao X; Ma X; Gao GF
    Emerg Microbes Infect; 2023 Dec; 12(2):2258232. PubMed ID: 37691586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anosmia or Ageusia Following COVID-19 Vaccination: A Systematic Review.
    Arabzadeh Bahri R; Esmaeilpur Abianeh F; Peisepar M; Hadi R; Basti FA; Maleki S; Radkhah H
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):164S-170S. PubMed ID: 38411125
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical presentation and outcomes of the first patients with COVID-19 in Argentina: Results of 207079 cases from a national database.
    Schönfeld D; Arias S; Bossio JC; Fernández H; Gozal D; Pérez-Chada D
    PLoS One; 2021; 16(2):e0246793. PubMed ID: 33571300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
    Bird O; Galiza EP; Baxter DN; Boffito M; Browne D; Burns F; Chadwick DR; Clark R; Cosgrove CA; Galloway J; Goodman AL; Heer A; Higham A; Iyengar S; Jeanes C; Kalra PA; Kyriakidou C; Bradley JM; Munthali C; Minassian AM; McGill F; Moore P; Munsoor I; Nicholls H; Osanlou O; Packham J; Pretswell CH; San Francisco Ramos A; Saralaya D; Sheridan RP; Smith R; Soiza RL; Swift PA; Thomson EC; Turner J; Viljoen ME; Heath PT; Chis Ster I
    Epidemiol Infect; 2024 Jan; 152():e37. PubMed ID: 38250791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran.
    Goshayeshi L; Akbari Rad M; Bergquist R; Allahyari A; Hashemzadeh K; ; Hoseini B
    BMC Infect Dis; 2021 Jul; 21(1):656. PubMed ID: 34233638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study.
    Nouchi A; Chastang J; Miyara M; Lejeune J; Soares A; Ibanez G; Saadoun D; Morélot-Panzini C; Similowski T; Amoura Z; Boddaert J; Caumes E; Bleibtreu A; Lorenzo A; Tubach F; Pourcher V
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):691-697. PubMed ID: 33033955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: COVID-19 Patient With Chief Complaint of Anosmia and Ageusia; a Unique Perspective on Atypical Symptomatology and Management in the Military.
    Smith LTAC; Hodges CDRJ; Pratt M; Porter IM
    Mil Med; 2020 Dec; 185(11-12):e2176-e2179. PubMed ID: 32776115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and epidemiological characteristics of 646 hospitalised SARS-Cov-2 positive patients in Rivers State Nigeria: a prospective observational study.
    Alasia D; Owhonda G; Maduka O; Nwadiuto I; Arugu G; Tobin-West C; Azi E; Oris-Onyiri V; Urang IJ; Abikor V; Olofinuka AM; Adebiyi O; Somiari A; Avundaa H; Alali A
    Pan Afr Med J; 2021; 38():25. PubMed ID: 33777293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.